These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Risk of cardiovascular disease and sudden death in schizophrenia. Davidson M J Clin Psychiatry; 2002; 63 Suppl 9():5-11. PubMed ID: 12088174 [TBL] [Abstract][Full Text] [Related]
44. Adverse effects of antipsychotic medications. Muench J; Hamer AM Am Fam Physician; 2010 Mar; 81(5):617-22. PubMed ID: 20187598 [TBL] [Abstract][Full Text] [Related]
45. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
46. [Antipsychotic drugs and cardiovascular safety: current studies of prolonged QT interval and risk of ventricular arrhythmia]. Gury C; Canceil O; Iaria P Encephale; 2000; 26(6):62-72. PubMed ID: 11217540 [TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs. Brown CS; Farmer RG; Soberman JE; Eichner SF Clin Pharmacokinet; 2004; 43(1):33-56. PubMed ID: 14715050 [TBL] [Abstract][Full Text] [Related]
48. Antipsychotic drugs & their side effects. Jaco R Indian J Med Res; 2009 Feb; 129(2):208-9; author reply 209. PubMed ID: 19293453 [No Abstract] [Full Text] [Related]
53. Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects. Siafis S; Tzachanis D; Samara M; Papazisis G Curr Neuropharmacol; 2018; 16(8):1210-1223. PubMed ID: 28676017 [TBL] [Abstract][Full Text] [Related]
54. Autonomic nervous system as a target for cardiovascular drugs. Bousquet P; Monassier L; Feldman J Clin Exp Pharmacol Physiol; 1998 Jun; 25(6):446-8. PubMed ID: 9673821 [TBL] [Abstract][Full Text] [Related]
55. "Don't worry, be happy"--may be a first line therapy in cardiovascular diseases? Bălan H; Popescu L Rom J Intern Med; 2013; 51(2):73-9. PubMed ID: 24294809 [TBL] [Abstract][Full Text] [Related]
56. ABC of poisoning. Cardiovascular, neurological, and other complications. Nielsen M; Henry J Br Med J (Clin Res Ed); 1984 Sep; 289(6446):681-6. PubMed ID: 6434040 [No Abstract] [Full Text] [Related]
57. [The effects of phenothiazine derivatives on structures in the autonomic nervous system]. BUDDE H; WITZLEB E Arch Int Pharmacodyn Ther; 1955 Jun; 102(1-2):126-38. PubMed ID: 13239253 [No Abstract] [Full Text] [Related]
58. A hypothesized mechanism for the cardiovascular risk associated with antipsychotic drug exposure and a potential preventive treatment. Foley DL Mol Psychiatry; 2014 Jan; 19(1):12-3. PubMed ID: 23247075 [No Abstract] [Full Text] [Related]